Wednesday, January 26, 2022
TRENDING
Stride, Inc. (NYSE: LRN) Reports Strong Fiscal Q2 Financial Results Amid Increasing Demand for Career Learning Services
January 26, 2022
Siyata Mobile (NASDAQ: SYTA) Leverages Partnerships and Strong Capitalization to Ramp Up for a Big Year in 2022
January 26, 2022
Sierra Oncology (NASDAQ: SRRA) Jumps After Momelotinib Pivotal Phase 3 MOMENTM Study Shows Promise in Treating Myelofibrosis Symptoms
January 25, 2022
A Novel Supply Concept From Obsidium (OBS) Sparks Interest
January 24, 2022
Next
Prev
Newsletter
Opinion
Market Snapshot
A Novel Supply Concept From Obsidium (OBS) Sparks Interest
Obsidium’s (OBS) timing may be unenviable, launching in the middle of a large crash in the market. Despite this, they’ve...
Read more
Exterran Corporation (NYSE: EXTN) Announces Merger With Enerflex, Ltd. (TSX: EFX) to Create Global Energy Infrastructure Giant
Exterran Corporation (NYSE: EXTN) is engaged as a global industrial systems and process company, focusing on the oil, gas, water...
Read moreAptorum Group (NASDAQ: APM) Granted FDA Orphan Drug Designation for SACT-1 and Treatment of Neuroblastoma
Aptorum Group Limited (NASDAQ: APM) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and...
Read moreZogenix (NASDAQ: ZGNX) to Be Acquired By UCB for $1.9 Billion
Zogenix, Inc. (NASDAQ: ZGNX) operates as a global biopharmaceutical company, which is focused on the research, development, and commercialization of...
Read more
ESChat and Siyata (NASDAQ: SYTA) Partner to Bring Broadband IoT Radio Push-to-Talk (PTT) Service to the US Markets
SAN LUIS OBISPO, Calif., Jan. 19, 2022 /PRNewswire/ -- ESChat today announced the availability of an integrated IoT Radio solution in...
Read moreLatest News
Exterran Corporation (NYSE: EXTN) Announces Merger With Enerflex, Ltd. (TSX: EFX) to Create Global Energy Infrastructure Giant
Exterran Corporation (NYSE: EXTN) is engaged as a global industrial systems and process company, focusing on the oil, gas, water...
Aptorum Group (NASDAQ: APM) Granted FDA Orphan Drug Designation for SACT-1 and Treatment of Neuroblastoma
Aptorum Group Limited (NASDAQ: APM) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and...
